Table of Contents
Journal of Cancer Research
Volume 2013 (2013), Article ID 801047, 5 pages
http://dx.doi.org/10.1155/2013/801047
Clinical Study

Correlating Pap Smear Results and Colposcopy-Directed Large Loop Excision of the Transformation Zone Histopathology in HIV-Infected and HIV-Uninfected Women: A Case-Control Study in South Africa

National Health Laboratory Service, Polokwane/Mankweng Hospital Complex, and University of Limpopo, Polokwane, Limpopo 0700, South Africa

Received 3 April 2013; Accepted 2 July 2013

Academic Editor: Kentaro Nakayama

Copyright © 2013 Louis-J. van Bogaert. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Lehtovirta, J. Paavonen, and O. Heikinheimo, “Risk factors, diagnosis and prognosis of cervical intraepithelial neoplasia among HIV-infected women,” International Journal of STD and AIDS, vol. 19, no. 1, pp. 37–41, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. D. N. Dames, C. Ragin, A. Griffith-Bowe, P. Gomez, and R. Butler, “The prevalence of cervical cytology abnormalities and human papillomavirus in women infected with the human immunodeficiency virus,” Infectious Agents and Cancer, vol. 4, no. 1, article S8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. L. S. Massad, G. D’Souza, F. Tian, H. Minkhoff, M. Cohen, R. L. Wright et al., “Negative predictive value of pap testing: implications for screening intervals for women with human immunodeficiency virus,” Obstetrics & Gynecology, vol. 120, no. 4, pp. 791–797, 2012. View at Google Scholar
  4. Centers for Disease Control and Prevention, “1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults,” Morbidity Mortality Weekly Report Recommendation Report, vol. 41, pp. 1–19, 1992. View at Google Scholar
  5. W. K. Sekirime and R. Gray, “HIV infection among Uganda women with cervical cancer: a retrospective study,” Gynecologic and Obstetric Investigation, vol. 63, no. 4, pp. 222–228, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. R. Moodley, M. Hoffman, H. Carrara et al., “HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study,” BMC Cancer, vol. 6, article 135, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. K. Chaturvedi, M. M. Madeleine, R. J. Biggar, and E. A. Engels, “Risk of human papillomavirus-associated cancers among persons with AIDS,” Journal of the National Cancer Institute, vol. 101, no. 16, pp. 1120–1130, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Bower, D. Mazhar, and J. Stebbing, “Should cervical cancer be an acquired immunodeficiency syndrome-defining cancer?” Journal of Clinical Oncology, vol. 24, no. 16, pp. 2417–2419, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. L.-J. Van Bogaert and D. C. Knapp, “Opportunistic testing of medically underserved women for cervical cancer in south africa,” Acta Cytologica, vol. 45, no. 3, pp. 313–316, 2001. View at Google Scholar · View at Scopus
  10. M. Hoffman, D. Cooper, H. Carrara et al., “Limited Pap screening associated with reduced risk of cervical cancer in South Africa,” International Journal of Epidemiology, vol. 32, no. 4, pp. 573–577, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Arbyn, R. Sankaranarayanan, R. Muwonge et al., “Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India,” International Journal of Cancer, vol. 123, no. 1, pp. 153–160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Cuzick, M. Arbyn, R. Sankaranarayanan et al., “Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries,” Vaccine, vol. 26, no. 10, pp. K29–K41, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. I. M. C. M. De Kok, J. Van Rosmalen, J. Dillner et al., “Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model,” British Medical Journal, vol. 344, no. 7847, article e670, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Kuhn, C. Wang, W.-Y. Tsai, T. C. Wright, and L. Denny, “Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected womens,” AIDS, vol. 24, no. 16, pp. 2553–2561, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. L. J. van Bogaert, “Cervical cancer prevention in resource-limited settings with special emphasis on areas of high cervical cancer and human immunodeficiency virus endemicity,” in Human Papillomavirus: Prevalence, Detection and Management, H. B. Smith, Ed., Novapublishers, New York, NY, USA, 2013. View at Google Scholar
  16. G. Ronco, P. Giorgi-Rossi, F. Carozzi et al., “Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test,” Journal of the National Cancer Institute, vol. 100, no. 7, pp. 492–501, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Naucler, W. Ryd, S. Törnberg et al., “Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening,” Journal of the National Cancer Institute, vol. 101, no. 2, pp. 88–99, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. H. van der Burg and J. M. Palefsky, “Human immunodeficiency virus and human papilloma virus—why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful,” Journal of Translational Medicine, vol. 7, p. 108, 2009. View at Google Scholar · View at Scopus
  19. T. M. Darragh, T. J. Colgan, T. Cox, D. Heller, M. Henry, R. Luff et al., “The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology,” International Journal of Gynecological Pathology, vol. 32, no. 1, pp. 76–115, 2013. View at Google Scholar
  20. V. V. Sahasrabuddhe, R. A. Bhosale, A. N. Kavatkar et al., “Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India,” International Journal of Cancer, vol. 130, no. 1, pp. 234–240, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Nanda, D. C. McCrory, E. R. Myers et al., “Accuracy of the papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review,” Annals of Internal Medicine, vol. 132, no. 10, pp. 810–819, 2000. View at Google Scholar · View at Scopus
  22. M. Branca, E. Rossi, M. Alderisio et al., “Performance of cytology and colposcopy in diagnosis of cervical intraepithelial neoplasia (CIN) in HIV-positive and HIV-negative women,” Cytopathology, vol. 12, no. 2, pp. 84–93, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Sankaranarayanan, A. M. Budukh, and R. Rajkumar, “Effective screening programmes for cervical cancer in low- and middle-income developing countries,” Bulletin of the World Health Organization, vol. 79, no. 10, pp. 954–962, 2001. View at Google Scholar · View at Scopus
  24. M.-H. Mayrand, E. Duarte-Franco, I. Rodrigues et al., “Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer,” The New England Journal of Medicine, vol. 357, no. 16, pp. 1579–1588, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. P. E. Gravitt, P. Paul, H. A. Katki et al., “Effectiveness of VIA, pap, and HPV DNA testing in a cervical cancer screening program in a Peri-Urban community in Andhra Pradesh, India,” PLoS ONE, vol. 5, no. 10, Article ID e13711, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. South African HPV advisory board, “Cervical cancer and human papillomavirus: South African guidelines for screening and testing,” Southern African Journal of Gynaecologic Oncology, vol. 2, no. 1, pp. 23–26, 2010. View at Google Scholar
  27. S. O. Albert, O. A. Oguntayo, and M. O. A. Samaila, “Comparative study of visual inspection of the cervix using acetic acid (VIA) and Papanicolaou (Pap) smears for cervical cancer screening,” Ecancer, vol. 6, article 262. View at Publisher · View at Google Scholar
  28. C. Firnhaber, N. Mayisela, S. Williams, A. Swarts, M. Faesen, S. Levin et al., “Validation of cervical screening methods in HIV positive women from Johannesburg South Africa,” Plos ONE, vol. 8, no. 1, Article ID e53494, 2013. View at Google Scholar
  29. P. E. Castle, M. H. Stoler, T. C. Wright, A. Sharma, T. L. Wright, and C. M. Behrens, “Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study,” The Lancet Oncology, vol. 12, no. 9, pp. 880–890, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Khuakoonratt, S. Tangjitgamol, S. Manusirivithaya et al., “Prevalence of high grade squamous intraepithelial lesion (HSIL) and invasive cervical cancer in patients with low grade squamous intraepithelial lesion (LSIL) at cervical pap smear,” Asian Pacific Journal of Cancer Prevention, vol. 9, no. 2, pp. 253–258, 2008. View at Google Scholar · View at Scopus
  31. R. Kiatiyosnusorn, P. Suprasert, J. Srisomboon, S. Siriaree, S. Khunamornpong, and C. Kietpeerakool, “High-grade histologic lesions in women with low-grade squamous intraepithelial lesion cytology from a region of Thailand with a high incidence of cervical cancer,” International Journal of Gynecology and Obstetrics, vol. 110, no. 2, pp. 133–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. P. A. de Lemos, M. T. Garcia-Zapata, and S. B. Tavares, “Cervical cytopathology in a population of HIV-positive and HIV-negative women,” Journal of Tropical Medicine, vol. 2012, Article ID 869758, 4 pages, 2012. View at Publisher · View at Google Scholar
  33. J. Atashili, W. C. Miller, J. S. Smithy, P. M. Ndumbe, G. M. Ikomey, J. Eron et al., “Age trends in the prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Cameroon: a cross-sectional study,” BMC Research Notes, vol. 5, article 590, 2012. View at Publisher · View at Google Scholar
  34. J. R. Anderson, P. Paramsothy, C. Heilig, D. J. Jamieson, K. Shah, and A. Duerr, “Accuracy of Papanicolaou test among HIV-infected women,” Clinical Infectious Diseases, vol. 42, no. 4, pp. 562–568, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. C. L. Curry, Y. H. Sage, O. Vragovic, and E. A. Stier, “Minimally abnormal pap testing and cervical histology in hiv-infected women,” Journal of Women's Health, vol. 21, no. 1, pp. 87–91, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Duerr, P. Paramsothy, D. J. Jamieson et al., “Effect of HIV infection on atypical squamous cells of undetermined significance,” Clinical Infectious Diseases, vol. 42, no. 6, pp. 855–861, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. L. A. Boardman, K. Cotter, C. Raker, and S. Cu-Uvin, “Cervical intraepithelial neoplasia grade 2 or worse in human immunodeficiency virus-infected women with mildly abnormal cervical cytology,” Obstetrics and Gynecology, vol. 112, no. 2, pp. 238–243, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. M. T. Galgano, P. E. Castle, K. A. Atkins, W. K. Brix, S. R. Nassau, and M. H. Stoler, “Using Biomarkers as objective standards in the diagnosis of cervical biopsies,” American Journal of Surgical Pathology, vol. 34, no. 8, pp. 1077–1087, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Nappi, C. Carriero, S. Bettocchi, J. Herrero, A. Vimercati, and G. Putignano, “Cervical squamous intraepithelial lesions of low-grade in HIV-infected women: recurrence, persistence, and progression, in treated and untreated women,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 121, no. 2, pp. 226–232, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Zeier, M. H. Botha, F. H. van der Merwe et al., “Progression and persistence of low-grade cervical squamous intraepithelial lesions in women living with human immunodeficiency virus,” Journal of Lower Genital Tract Disease, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Alsharif, K. Kjeldahl, C. Curran, S. Miller, H. E. Gulbahce, and S. E. Pambuccian, “Clinical significance of the diagnosis of low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion,” Cancer Cytopathology, vol. 117, no. 2, pp. 92–100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. M. J. Thrall, D. A. Smith, and D. R. Mody, “Women ≥30 years of age with low grade squamous intraepithelial lesion (LSIL) have low positivity rates when cotested for high-risk human papillomavirus: should we reconsider HPV triage for LSIL in older women?” Diagnostic Cytopathology, vol. 38, no. 6, pp. 407–412, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. “National Department of Health, South Africa “ National Guideline on Cervical Cancer Screening Programme” , Pretoria,” 2003.